HDII (Hypertension Diagnostics) Total Stockholders Equity: $-4.75 Mil (As of Sep. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hypertension Diagnostics Total Stockholders Equity?

Hypertension Diagnostics HDII -99.00% Total Stockholders Equity is $-4.75 Mil as of Sep. 2019.

Hypertension Diagnostics's Total Stockholders Equity for the quarter that ended in Sep. 2019 was $-4.75 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hypertension Diagnostics's Book Value per Share for the quarter that ended in Sep. 2019 was $-0.09. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hypertension Diagnostics's Debt-to-Equity for the quarter that ended in Sep. 2019 was -0.99.


Hypertension Diagnostics  (OTCPK:HDII) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hypertension Diagnostics's Book Value per Share for the quarter that ended in Sep. 2019 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hypertension Diagnostics's Debt-to-Equity for the quarter that ended in Sep. 2019 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hypertension Diagnostics Total Stockholders Equity Related Terms


Hypertension Diagnostics Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Hypertension Diagnostics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics Total Stockholders Equity Chart

Hypertension Diagnostics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Dec16 Dec17 Dec18
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 -0.29 -4.26 -4.63 -4.75

Hypertension Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.63 -4.75 -4.75 -4.75 -4.75
What does a Total Stockholders Equity of $-4.75 Mil mean?
Hypertension Diagnostics (HDII) has a Total Stockholders Equity of $-4.75 Mil as of Sep. 2019. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Hypertension Diagnostics and its competitors.
Is Hypertension Diagnostics' Total Stockholders Equity too high?
Hypertension Diagnostics' current Total Stockholders Equity is $-4.75 Mil.
How does Hypertension Diagnostics' Total Stockholders Equity compare to ESTRF and OCLN?
Hypertension Diagnostics' Total Stockholders Equity of $-4.75 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Diversified Financial Services company?
A good Total Stockholders Equity depends on the Diversified Financial Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Hypertension Diagnostics and its competitors. Hypertension Diagnostics's current Total Stockholders Equity is $-4.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypertension Diagnostics stock overvalued right now?
Hypertension Diagnostics (HDII) has a current Total Stockholders Equity of $-4.75 Mil. The current Total Stockholders Equity is $-4.75 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Hypertension Diagnostics (HDII), the current Total Stockholders Equity is $-4.75 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.